Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry and multivariate statistical analysis

BMC Nephrology

Volumn 15, Issue 1, 2014, Pages

  Kalantari, Shiva ^a   Nafar, Mohsen ^a,b,c   Rutishauser, Dorothea ^d,e   Samavat, Shiva ^b   Rezaei Tavirani, Mostafa ^f   Yang, Hongqian ^d   Zubarev, Roman A ^d,e  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KAROLINSKA INSTITUTE   (Sweden)

^e SCIENCE FOR LIFE LABORATORY   (Sweden)

^f SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Inflammatory response; Responsiveness; Urine proteomics

Indexed keywords

APOLIPOPROTEIN A1; PREDNISOLONE; PROTEOME; STEROID; BIOLOGICAL MARKER; CORTICOSTEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DRUG MEGADOSE; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENE ONTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; KIDNEY BIOPSY; LIQUID CHROMATOGRAPHY; MALE; PILOT STUDY; PROTEIN ANALYSIS; PROTEOMICS; STEROID THERAPY; TANDEM MASS SPECTROMETRY; URINALYSIS; VALIDATION STUDY; ADOLESCENT; DIET; DRUG RESISTANCE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GLOMERULUS FILTRATION RATE; MIDDLE AGED; NANOTECHNOLOGY; PREDICTIVE VALUE; PROCEDURES; PROTEINURIA; SMOKING; URINE; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; DIET; DRUG RESISTANCE; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NANOTECHNOLOGY; PREDICTIVE VALUE OF TESTS; PROTEINURIA; PROTEOMICS; SMOKING; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84907795725     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-15-141     Document Type: Article

References (51)

1. Pathologic classification of focal segmental glomerulosclerosis. D'Agati VD, Semin Nephrol 2003 23 117 134 10.1053/snep.2003.50012 12704572
2. Idiopathic focal segmental glomerulosclerosis. Schnaper HW, Semin Nephrol 2003 23 183 193 10.1053/snep.2003.50016 12704578
3. Pathophysiology of focal segmental glomerulosclerosis. Reidy K, Kaskel FJ, Pediatr Nephrol 2007 22 350 354 10.1007/s00467-006-0357-2 17216262
4. Nephrotic syndrome in childhood. Eddy AA, Symons JM, Lancet 2003 362 629 639 10.1016/S0140-6736(03)14184-0 12944064
5. Very low-molecular-mass fragments of albumin in the plasma of patients with focal segmental glomerulosclerosis. Hellin JL, Bech-Serra JJ, Moctezuma EL, Chocron S, Santin S, Madrid A, Vilalta R, Canals F, Torra R, Meseguer A, Nieto JL, Am J Kidney Dis 2009 54 871 880 10.1053/j.ajkd.2009.07.011 19781833
6. Urine proteomic profiling of pediatric nephrotic syndrome. Khurana M, Traum AZ, Aivado M, Welles MP, Guerrero M, Grall F, Libermann TA, Schachter AD, Pediatr Nephrol 2006 21 1257 1265 10.1007/s00467-006-0165-8 16810512
7. Urine proteomic profiling to identify biomarkers of steroid resistance in pediatric nephrotic syndrome. Traum AZ, Expert Rev Proteomics 2008 5 715 719 10.1586/14789450.5.5.715 18937561
8. How does glomerular epithelial cell injury contribute to progressive glomerular damage? Rennke HG, Kidney Int Suppl 1994 45 58 S63 10.1038/ki.1994.7 8158900
9. Biomarker discovery in glomerular diseases using urinary proteomics. Thongboonkerd V, Proteomics Clin Appl 2008 2 1413 1421 10.1002/prca.200800036 21136790
10. Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood. Woroniecki RP, Orlova TN, Mendelev N, Shatat IF, Hailpern SM, Kaskel FJ, Goligorsky MS, O'Riordan E, Am J Nephrol 2006 26 258 267 10.1159/000093814 16763371
11. Repetitive fragmentation product of albumin and -1 antitrypsin in glomerular disease associated with nephrotic syndrome. Candiano G, Musante L, Bruschi M, Petretto A, Santucci L, Del Boccio P, Pavone B, Perfumo F, Urbani A, Scolari F, Ghiggeri GM, J Am Soc Nephrol 2006 17 3139 3148 10.1681/ASN.2006050486 17005933
12. In silico instrumental response correction improves precision of label-free proteomics and accuracy of proteomics-based predictive models. Lyutvinskiy Y, Yang H, Rutishauser D, Zubarev RA, Mol Cell Proteomics 2013 12 2324 2331 10.1074/mcp.O112.023804 23589346
13. Regression on multivariate images principal component regression for modeling, prediction and visual diagnostic-tools. Geladi P, Esbensen K, J Chemometr 1991 5 97 111 10.1002/cem.1180050206
14. DNA and peptide sequences and chemical processes multivariately modeled by principal component analysis and partial least-Squares projections to latent structures. Wold S, Jonsson J, Sjostrom M, Sandberg M, Rannar S, Anal Chim Acta 1993 277 239 253 10.1016/0003-2670(93)80437-P
15. Jackson JE, A User's Guide to Principal Components New York: John Wiley and sons 1991
16. A combined proteomic and transcriptomic approach shows diverging molecular mechanisms in thoracic aortic aneurysm development in patients with tricuspid- and bicuspid aortic valve. Kjellqvist S, Maleki S, Olsson T, Chwastyniak M, Branca RM, Lehtiö J, Pinet F, Franco-Cereceda A, Eriksson P, Mol Cell Proteomics 2013 12 407 425 10.1074/mcp.M112.021873 23184916
17. Orthogonal projections to latent structures (O-PLS). Trygg J, Wold S, J Chemometr 2002 16 119 128 10.1002/cem.695
18. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Broadhurst DI, Kell DB, Metabolomics 2006 2 171 196
19. An introduction to ROC analysis. Fawcett T, Pattern Recogn Lett 2006 27 861 874 10.1016/j.patrec.2005.10.010
20. DAVID: database for annotation, visualization, and integrated discovery. Dennis GJ-R, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA, Genome Biol 2003 4 3 10.1186/gb-2003-4-5-p3 12734009
21. Identifying biological themes within lists of genes with EASE. Hosack DA, Dennis GJ-R, Sherman BT, Lane HC, Lempicki RA, Genome Biol 2003 4 70 10.1186/gb-2003-4-10-r70 14519205
22. Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: Inhibition of oxidation of low density lipoproteins. Kunitake ST, Jarvis MR, Hamilton RL, Kane JP, Proc Natl Acad Sci U S A 1992 89 6993 6997 10.1073/pnas.89.15.6993 1495991
23. Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia. Zachariah JP, Colan SD, Lang P, Triedman JK, Alexander ME, Walsh EP, Berul CI, Cecchin F, Circ Heart Fail 2012 5 462 466 10.1161/CIRCHEARTFAILURE.111.966200 22628530
24. Urine glycoprotein profile reveals novel markers for chronic kidney disease. Vivekanandan-Giri A, Slocum JL, Buller CL, Basrur V, Ju W, Pop-Busui R, Lubman DM, Kretzler M, Pennathur S, Int J Proteomics 2011 2011 214715 22091387
25. Characterization of a 280-kD protein restricted to the coated pits of the renal brush border and the epithelial cells of the yolk sac. Sahali D, Mulliez N, Chatelet F, Dupuis R, Ronco P, Verroust P, J Exp Med 1988 167 213 218 10.1084/jem.167.1.213 2891781
26. Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis. Hammad SM, Stefansson S, Twal WO, Drake CJ, Fleming P, Remaley A, Brewer HB Jr, Argraves WS, Proc Natl Acad Sci U S A 1999 96 10158 10163 10.1073/pnas.96.18.10158 10468579
27. The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein. Kozyraki R, Fyfe J, Kristiansen M, Gerdes C, Jacobsen C, Cui S, Christensen EI, Aminoff M, de la Chapelle A, Krahe R, Verroust PJ, Moestrup SK, Nat Med 1999 5 656 661 10.1038/9504 10371504
28. Cubilin and megalin: partners in lipoprotein and vitamin metabolism. Barth JL, Argraves WS, Trends Cardiovasc Med 2001 11 26 31 10.1016/S1050-1738(01)00080-9 11413049
29. Antroquinonol reduces oxidative stress by enhancing the Nrf2 signaling pathway and inhibits inflammation and sclerosis in focal segmental glomerulosclerosis mice. Tsai PY, Ka SM, Chao TK, Chang JM, Lin SH, Li C, Kuo MT, Chen P, Chen A, Free Radic Bio Med 2011 50 1503 1516 10.1016/j.freeradbiomed.2011.02.029
30. Focal segmental glomerulosclerosis: pathogenesis and treatment. Benchimol C, Curr Opin Pediatr 2003 15 171 180 10.1097/00008480-200304000-00006 12640274
31. Acute inflammation is the harbinger of glomerulosclerosis in anti-glomerular basement membrane nephritis. Scandrett AL, Kissane J, Lefkowith JB, Renal Physiol 1995 268 258 F265
32. Depletion of clusterin in renal diseases causing nephrotic syndrome. Ghiggeri GM, Bruschi M, Candiano G, Rastaldi MP, Scolari F, Passerini P, Musante L, Pertica N, Caridi G, Ferrario F, Perfumo F, Ponticelli C, Kidney Int 2002 62 2184 2194 10.1046/j.1523-1755.2002.00664.x 12427144
33. Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis. Candiano G, Musante L, Carraro M, Faccini L, Campanacci L, Zennaro C, Artero M, Ginevri F, Perfumo F, Gusmano R, Ghiggeri GM, J Am Soc Nephrol 2001 12 143 150 11134260
34. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F, N Engl J Med 1996 334 878 883 10.1056/NEJM199604043341402 8596570
35. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacgues Y, de Hurault Ligny B, Niaudet P, Charpentier B, Soulillou JP, N Engl J Med 1994 330 7 14 10.1056/NEJM199401063300102 8259160
36. Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Hochepied T, Berger FG, Baumann H, Libert C, Cytokine Growth Factor Rev 2003 14 25 34 10.1016/S1359-6101(02)00054-0 12485617
37. Urine biomarkers predict the cause of glomerular disease. Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, Arthur JM, J Am Soc Nephrol 2007 18 913 922 10.1681/ASN.2006070767 17301191
38. 1-acid glycoprotein. Fuse E, Tanii H, Kurata N, Kobayashi H, Shimada Y, Amura T, Sasaki Y, Tanigawara Y, Lush RD, Headlee D, Figg WD, Arbuck SG, Senderowicz AM, Sausville EA, Akinaga S, Kuwabara T, Kobayashi S, Cancer Res 1998 58 3248 3253 9699650
39. - 1 acid glycoprotein binds to Imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients. Gambacorti-Passerini C, Zucchetti M, Russo D, Frapolli R, Verga M, Bungaro S, Tornaghi L, Rossi F, Pioltelli P, Pogliani E, Alberti D, Corneo G, D'Incalci M, Clin Cancer Res 2003 9 625 632 12576428
40. Multi-functional capability of proteins: 1-antichymotrypsin and the correlation with Alzheimer's disease. Zhanga S, Janciauskiene S, J Alzheimers Dis 2002 4 115 122 12214135
41. Characterization of urinary peptide biomarkers of AR in renal allografts. O'Riordan E, Orlova TN, Podust VN, Am J Transplant 2007 7 930 940 10.1111/j.1600-6143.2007.01733.x 17331118
42. Basement membrane proteoglycans: from cellar to ceiling. Iozzo RV, Nat Rev Mol Cell Biol 2005 6 646 656 10.1038/nrm1702 16064139
43. Heparan sulfate of perlecan is involved in glomerular filtration. Morita H, Yoshimura A, Inui K, Ideura T, Watanabe H, Wang L, Soininen R, Tryggvason K, J Am Soc Nephrol 2005 16 1703 1710 10.1681/ASN.2004050387 15872080
44. The use of polyethyleneimine for demonstration of anionic sites in basement membranes and collagen fibers. Schurer JW, Kalicharan D, Hoedemaeker PJ, Molenaar I, J Histochem Cytochem 1978 26 688 689 10.1177/26.8.690407 690407
45. Characterization of heparan sulfate proteoglycan of glomerular basement membranes. Kanwar YS, Veis A, Kimura JH, Jakuboski ML, Proc Natl Acad Sci U S A 1984 81 762 766 10.1073/pnas.81.3.762 6230667
46. Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats. Rienstra H, Katta K, Celie JW, van Goor H, Navis G, van den Born J, Hillebrands JL, PLoS One 2010 5 9095 10.1371/journal.pone.0009095 20140097
47. The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. Rybakova IN, Patel JR, Ervasti JM, J Cell Biol 2000 150 1209 1214 10.1083/jcb.150.5.1209 10974007
48. Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Ransom RF, Lam NG, Hallett MA, Atkinson SJ, Smoyer WE, Kidney Int 2005 68 2473 2483 10.1111/j.1523-1755.2005.00723.x 16316324
49. Amino acid sequence of human plasma a1B-glycoprotein: homology to the immunoglobulin supergene family. Ishioka N, Takahashi N, Putnam FW, Proc Natl Acad Sci U S A 1986 83 2363 2367 10.1073/pnas.83.8.2363 3458201
50. Discovery and initial validation of 1-B glycoprotein fragmentation as a differential urinary biomarker in pediatric steroid-resistant nephrotic syndrome. Piyaphanee N, Ma Q, Kremen O, Czech K, Greis K, Mitsnefes M, Devarajan P, Bennett MR, Proteomics Clin Appl 2011 5 334 342 10.1002/prca.201000110 21591266
51. Comparison of urinary proteomics between steroid-sensitive and steroid-resistant minimal change nephrotic syndrome in children. Huang YJ, Huang SM, Zhang AH, Zheng G, Chen RH, Nan Fang Yi Ke Da Xue Xue Bao 2007 27 1507 1510 17959526